4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000088
Chief Operating Officer sold 5,000 shares at an average $91.82 ($459,101)
- Chief Operating Officer acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Sandler Laura Lee · Chief Operating Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +5,000 | $7.80 | $39,000 | 241,384 | D |
| 2026-09-01 | Sale : show line 2 in the form 10b5-1 | −1,000 | $91.05 | $91,048 | 240,384 | D |
| 2026-09-01 | Sale : show line 3 in the form 10b5-1 | −4,000 | $92.01 | $368,054 | 236,384 | D |
| Open-market sales · 5,000 sh · avg $91.82 · $459,101 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-01 | Exercise or conversion : show line 4 in the form 10b5-1 Employee Warrant (right to buy) | −5,000 | 74,996 | D |
Loading xslF345X06/form4.xml…